These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 25514222)

  • 1. Prodrug strategies for enhancing the percutaneous absorption of drugs.
    N'Da DD
    Molecules; 2014 Dec; 19(12):20780-807. PubMed ID: 25514222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prodrug strategy for enhancing drug delivery via skin.
    Fang JY; Leu YL
    Curr Drug Discov Technol; 2006 Sep; 3(3):211-24. PubMed ID: 17311566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prodrugs for transdermal drug delivery - trends and challenges.
    Ita KB
    J Drug Target; 2016 Sep; 24(8):671-8. PubMed ID: 26878159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A duplex "Gemini" prodrug of naltrexone for transdermal delivery.
    Hammell DC; Hamad M; Vaddi HK; Crooks PA; Stinchcomb AL
    J Control Release; 2004 Jun; 97(2):283-90. PubMed ID: 15196755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of Ketorolac ester prodrugs for transdermal delivery.
    Doh HJ; Cho WJ; Yong CS; Choi HG; Kim JS; Lee CH; Kim DD
    J Pharm Sci; 2003 May; 92(5):1008-17. PubMed ID: 12712420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketorolac amide prodrugs for transdermal delivery: stability and in vitro rat skin permeation studies.
    Kim BY; Doh HJ; Le TN; Cho WJ; Yong CS; Choi HG; Kim JS; Lee CH; Kim DD
    Int J Pharm; 2005 Apr; 293(1-2):193-202. PubMed ID: 15778057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ester prodrugs of morphine improve transdermal drug delivery: a mechanistic study.
    Wang JJ; Sung KC; Huang JF; Yeh CH; Fang JY
    J Pharm Pharmacol; 2007 Jul; 59(7):917-25. PubMed ID: 17637185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prodrugs of gestodene for matrix-type transdermal drug delivery systems.
    Lipp R; Laurent H; Günther C; Riedl J; Esperling P; Täuber U
    Pharm Res; 1998 Sep; 15(9):1419-24. PubMed ID: 9755895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal delivery and cutaneous targeting of antivirals using a penetration enhancer and lysolipid prodrugs.
    Diblíková D; Kopečná M; Školová B; Krečmerová M; Roh J; Hrabálek A; Vávrová K
    Pharm Res; 2014 Apr; 31(4):1071-81. PubMed ID: 24271238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of transdermal apomorphine delivery with a diester prodrug strategy.
    Liu KS; Sung KC; Al-Suwayeh SA; Ku MC; Chu CC; Wang JJ; Fang JY
    Eur J Pharm Biopharm; 2011 Aug; 78(3):422-31. PubMed ID: 21315820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermal delivery of therapeutic agents using dendrimers (US20140018435A1): a patent evaluation.
    Yang J; Hu J; He B; Cheng Y
    Expert Opin Ther Pat; 2015; 25(10):1209-14. PubMed ID: 26150049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect and Mechanism of Transdermal Penetration Enhancement of Fu's Cupping Therapy: New Physical Penetration Technology for Transdermal Administration with Traditional Chinese Medicine (TCM) Characteristics.
    Xie WJ; Zhang YP; Xu J; Sun XB; Yang FF
    Molecules; 2017 Mar; 22(4):. PubMed ID: 28346390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amorphous Solid Dispersions or Prodrugs: Complementary Strategies to Increase Drug Absorption.
    Rumondor ACF; Dhareshwar SS; Kesisoglou F
    J Pharm Sci; 2016 Sep; 105(9):2498-2508. PubMed ID: 26886316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal delivery of contraceptives.
    Friend DR
    Crit Rev Ther Drug Carrier Syst; 1990; 7(2):149-86. PubMed ID: 2272099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential oils and their constituents as skin penetration enhancer for transdermal drug delivery: a review.
    Herman A; Herman AP
    J Pharm Pharmacol; 2015 Apr; 67(4):473-85. PubMed ID: 25557808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of ester promoieties on transdermal delivery of ketorolac.
    Liu KS; Hsieh PW; Aljuffali IA; Lin YK; Chang SH; Wang JJ; Fang JY
    J Pharm Sci; 2014 Mar; 103(3):974-86. PubMed ID: 24481782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic approaches to enhance transdermal drug delivery. 1. Effect of lipid synthesis inhibitors.
    Tsai JC; Guy RH; Thornfeldt CR; Gao WN; Feingold KR; Elias PM
    J Pharm Sci; 1996 Jun; 85(6):643-8. PubMed ID: 8773963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of esmolol prodrugs for transdermal delivery.
    Bijaya G; Kaushal D; Sonal D; Pallavi K
    Drug Deliv; 2010; 17(7):532-40. PubMed ID: 20553111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microemulsions as transdermal drug delivery vehicles.
    Kogan A; Garti N
    Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of methoxypoly(ethylene glycol) carbonate prodrugs of zidovudine and penetration through human skin in vitro.
    N'da DD; Breytenbach JC
    J Pharm Pharmacol; 2009 Jun; 61(6):721-31. PubMed ID: 19505362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.